🇦🇺 Australia Country × Condition
solid tumors Clinical Trials in Australia
Active clinical trials for solid tumors with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Enrollment
362 pts
Country
🇦🇺 Australia
Arcus Biosciences, Inc.
View Trial → NCT05203172 Phase 4
Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Enrollment
46 pts
Country
🇦🇺 Australia
Pfizer
View Trial → NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Enrollment
170 pts
Country
🇦🇺 Australia
Mirati Therapeutics Inc.
View Trial → NCT06816992 Phase 1
Recruiting
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
Enrollment
76 pts
Country
🇦🇺 Australia
ORIC Pharmaceuticals
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in Australia?
There are currently 4 active clinical trials for solid tumors with sites in Australia, of which 4 are actively recruiting patients.
How can I join a solid tumors clinical trial in Australia?
To join a solid tumors clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in Australia?
Active solid tumors trials in Australia span Phase 1, Phase 4, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology